| Outgoing Relation(s) |
| (4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid (CHEBI:137349) has role anti-inflammatory agent (CHEBI:67079) |
| (4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid (CHEBI:137349) has role human xenobiotic metabolite (CHEBI:76967) |
| (4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid (CHEBI:137349) is a dihydroxydocosahexaenoic acid (CHEBI:137348) |
| (4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid (CHEBI:137349) is a secondary allylic alcohol (CHEBI:134396) |
| (4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid (CHEBI:137349) is a ω-hydroxy-long-chain fatty acid (CHEBI:140997) |
| (4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid (CHEBI:137349) is conjugate acid of (4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoate (CHEBI:136529) |
| (4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid (CHEBI:137349) is enantiomer of (4Z,7Z,10Z,12E,14R,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid (CHEBI:137350) |
| Incoming Relation(s) |
| (4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoate (CHEBI:136529) is conjugate base of (4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid (CHEBI:137349) |
| (4Z,7Z,10Z,12E,14R,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid (CHEBI:137350) is enantiomer of (4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid (CHEBI:137349) |